Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue

Journal of the National Cancer Institute

Volumn 90, Issue 9, 1998, Pages 691-697

  Basak, Saroj ^a   Speicher, David ^a   Eck, Stephen ^b   Wunner, William ^a   Maul, Gerd ^a   Simmons, Michael S ^c   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; MATRIGEL; RECOMBINANT PROTEIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; COLONY FORMATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; TUMOR GROWTH;

EID: 0032490120     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.9.691     Document Type: Article

References (37)

1. Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A 1979;76:1438-52.
2. Herlyn D, Herlyn M, Ross AH, Ernst C, Atkinson B, Koprowski H. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 1984;73:157-67.
3. Ross AH, Herlyn D, Iliopoulos D, Koprowski H. Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun 1986;135:297-303.
4. Gottlinger HG, Funke I, Johnson JP, Gokel JM, Riethmuller G. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 1986;38:47-53.
5. Herlyn M, Steplewski Z, Herlyn D, Koprowski H. CO 17-1A and related monoclonal antibodies: their production and characterization. Hybridoma 1986;5 Suppl 1:83-10.
6. Shetye J, Frodin JE, Christensson B, Grant C, Jacobsson B, Sundelius S, et al. Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunol Immunother 1988;27:154-62.
7. Shetye J, Christensson B, Rubio C, Rodensjo M, Biberfeld P, Mellstedt H. The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues. Anticancer Res 1989;9:395-404.
8. Sears HF, Herlyn D, Herlyn M, Grotzinger PJ, Steplewski Z, Gerhard W, et al. Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. J Surg Res 1981;31:145-50.
9. Sears HF, Herlyn D, Herlyn M, Steplewski Z, Grotzinger P, Koprowski H. Ex vivo perfusion of human colon with monoclonal anticolorectal cancer antibodies. Cancer 1982;49:1231-5.
10. Mach JP, Chatal JF, Lumbroso JD, Buchegger F, Forni M, Ritschard C, et al. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res 1983;43:5593-600.
11. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 1994;343:1177-83.
12. Herlyn D, Wettendorff M, Schmoll E, Iliopoulos D, Schedel I, Dreikhausen U, et al. Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci U S A 1987;84:8055-9.
13. Loibner H, Plot R, Rot A, Werner G, Wrann M, Samonigg H, et al. Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypes [letter]. Lancet 1990;335:171.
14. Herlyn D, Benden A, Kane M, Somasundaram R, Zaloudik J, Sperlagh M, et al. Anti-idiotype cancer vaccines: pre-clinical and clinical studies. In Vivo 1991;5:615-23.
15. Herlyn D, Harris D, Zaloudik J, Sperlagh M, Maruyama H, Jacob L, et al. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients. J Immunother Emphasis Tumor Immunol 1994;15:303-11.
16. Somasundaram R, Zaloudik J, Jacob L, Benden A, Sperlagh M, Hart E, et al. Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody. J Immunol 1995;155:3253-61.
17. Herlyn D, Zaloudik J, Li W, Wunner WW, Speicher DW, Linnenbach A, et al. Preclinical and clinical evaluation of baculovirus-derived gastrointestinal carcinoma-associated antigen CO17-1A/GA733 [abstract]. Proc Am Assoc Cancer Res 1997;38:399.
18. Li W, Berencsi K, Basak S, Somasundaram R, Ricciardi RP, Gonczol E, et al. Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice. J Immunol 1997;159:763-9.
19. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 1994;125:437-46.
20. Bergsagel PL, Victor-Kobrin C, Timblin CR, Trepel J, Kuehl WM. A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J Immunol 1992;148:590-6.
21. Maruyama H, Benden A, Li W, Zaloudik J, Koido T, Taupin JL, et al. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int J Cancer 1996;65:547-53.
22. Herlyn M, Balaban G, Bennicelli J, Guerry D 4th, Halaban R, Herlyn D, et al. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 1985;74:283-9.
23. Strassburg CP, Kasai Y, Seng BA, Miniou P, Zaloudik J, Herlyn D, et al. Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen. Cancer Res 1992;52:815-21.
24. Zaloudik J, Basak S, Nesbit M, Speicher DW, Wunner WH, Miller E, et al. Expression of an antigen homologous to the human CO17-1A/ GA733 colon cancer antigen in animal tissues. Br J Cancer 1997;76:909-16.
25. Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H, et al. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci U S A 1990;87:3542-6.
26. Iliopoulos D, Ernst C, Steplewski Z, Jambrosic JA, Rodeck U, Herlyn M, et al. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst 1989;81:440-4.
27. Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994;54:2514-20.
28. Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin Exp Metastasis 1994;12:324-8.
29. Brattain MG, Strobel-Stevens J, Fine D, Webb M, Sarrif AM. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res 1980;40:2142-6.
30. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 1979;5:957-71.
31. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996;56:4063-70.
32. Watabe M, Nagafuchi A, Tsukita S, Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 1994;127:247-56.
33. Liu D, Nigam AK, Lalani EN, Stamp GW, Pignatelli M. Transfection of E-cadherin into a human colon carcinoma cell line induces differentiation and inhibits growth in vitro. Gut 1993;34:S27.
34. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell - cell adhesion. J Cell Biol 1989;108:2435-47.
35. Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res 1996;56:3431-5.
36. 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci U S A 1995;92:7411-5.
37. Tanabe KK, Stamenkovic I, Cutler M, Takahashi K. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann Surg 1995;222:493-501.